Follow GE HealthCare to never miss an important update.
GE HealthCare has appointed William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. He joins from Xylem, a water technology company, where he held the same role. He will take over from George A. Newcomb, who has been filling the role temporarily and will return to his position as the company's Controller and Chief Accounting Officer.
Finding a permanent finance leader is an important step for the company as it continues to manage its debt and improve its profit margins after spinning off from GE. Grogan's experience at other industrial and engineering firms suggests he is well-suited to help the company shift toward more software and service revenue, which is central to its long-term growth plan.
Source: 8-K filing
The new LOGIQ e family includes two portable systems designed for fast imaging outside of traditional hospital rooms. These machines use artificial intelligence to help doctors automate parts of the scanning process. This rollout supports the company's goal of using software to make its hardware more valuable to busy medical staff.
Source: Business Wire
The Invenia ABUS Prime and the StreamVue viewer are designed to improve cancer screening for women with dense breast tissue. The viewer received 510(k) clearance, which is the standard FDA process for proving a new medical device is safe and effective by comparing it to existing products.
This launch is a clear example of the company's plan to grow its high-margin software business. By providing tools that allow doctors to review exams across an entire hospital network, the company makes its imaging hardware more central to a hospital's daily operations.
Source: Business Wire
The firm kept its positive rating on the stock after the company reported better-than-expected results. This small target increase reflects confidence in the company's ability to grow its orders and manage its costs as a standalone business.
Source: Evercore ISI
Revenue grew about 6 percent to $5.29 billion, slightly ahead of what Wall Street expected. The most important detail for long-term owners was the record $23.9 billion backlog of future work, with new orders growing 11 percent. This suggests that hospitals are still investing heavily in the MRI and CT scanners that drive the company's business.
Management also noted they are looking at strategic options for the Patient Care Solutions unit, which handles things like patient monitors. This could mean a sale or spin-off of that slower-growing division, which would allow the company to focus more on its higher-margin imaging and digital software goals.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
Analysts have recently maintained their positions following the company's late July earnings report and subsequent product launches. Ten of 18 analysts rate the stock a buy, and the average target of $79 suggests a modest 4% upside.
Management consistently sets a reachable bar and clears it, with seven beats in the last eight quarters showing they have a firm handle on their costs and hospital demand.
| Expectation | |
|---|---|
| EPS | $1.21 |
| Revenue | $5.35B |
Follow GE HealthCare to get the latest and most important updates.
Follow GEHC